Cargando…

An Analysis of the Social and Economic Costs of Breast Cancer in Italy

Background: Breast cancer is the most prevalent cancer affecting women and it represents an important economic burden. The aim of this study was to estimate the socio-economic burden of breast cancer (BC) in Italy both from the National Health Service (NHS) and the government perspectives (costs bor...

Descripción completa

Detalles Bibliográficos
Autores principales: Mennini, Francesco Saverio, Trabucco Aurilio, Marco, Gazzillo, Simone, Nardone, Claudia, Sciattella, Paolo, Marcellusi, Andrea, Migliorini, Raffaele, Sciannamea, Valerio, Piccioni, Andrea, Bolcato, Matteo, Barni, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431604/
https://www.ncbi.nlm.nih.gov/pubmed/34501588
http://dx.doi.org/10.3390/ijerph18179005
_version_ 1783750976655589376
author Mennini, Francesco Saverio
Trabucco Aurilio, Marco
Gazzillo, Simone
Nardone, Claudia
Sciattella, Paolo
Marcellusi, Andrea
Migliorini, Raffaele
Sciannamea, Valerio
Piccioni, Andrea
Bolcato, Matteo
Barni, Sandro
author_facet Mennini, Francesco Saverio
Trabucco Aurilio, Marco
Gazzillo, Simone
Nardone, Claudia
Sciattella, Paolo
Marcellusi, Andrea
Migliorini, Raffaele
Sciannamea, Valerio
Piccioni, Andrea
Bolcato, Matteo
Barni, Sandro
author_sort Mennini, Francesco Saverio
collection PubMed
description Background: Breast cancer is the most prevalent cancer affecting women and it represents an important economic burden. The aim of this study was to estimate the socio-economic burden of breast cancer (BC) in Italy both from the National Health Service (NHS) and the government perspectives (costs borne by the social security system). Methods: The economic analysis was based on the costs incurred by the NHS from 2008 to 2016 (direct costs related to hospitalizations) and by the National Social Security Institute (INPS) from 2009 to 2015 (costs of social security benefits) for patients with breast cancer. The analysis was based on the Hospital Information System (HIS) and Disability Insurance Awards databases. For both databases, patients affected by a malignant neoplasm of the female breast, carcinoma in situ, or secondary malignant neoplasm of the breast were considered. Results: Results show that more than 75,000 women were hospitalized for breast cancer every year, with an overall cost for hospitalization of about €300 million per year. From the Social Security analysis, a number of 29,000 beneficiaries each year was estimated. Considering per patient social costs, breast cancer at the primary stage cost €8828 per year, while secondary neoplasms cost €9780, with an average total economic burden of €257 million per year. Conclusions: This analysis focused on the economic impact of breast cancer in Italy, showing that an advanced stage of the disease was associated with a higher cost.
format Online
Article
Text
id pubmed-8431604
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84316042021-09-11 An Analysis of the Social and Economic Costs of Breast Cancer in Italy Mennini, Francesco Saverio Trabucco Aurilio, Marco Gazzillo, Simone Nardone, Claudia Sciattella, Paolo Marcellusi, Andrea Migliorini, Raffaele Sciannamea, Valerio Piccioni, Andrea Bolcato, Matteo Barni, Sandro Int J Environ Res Public Health Article Background: Breast cancer is the most prevalent cancer affecting women and it represents an important economic burden. The aim of this study was to estimate the socio-economic burden of breast cancer (BC) in Italy both from the National Health Service (NHS) and the government perspectives (costs borne by the social security system). Methods: The economic analysis was based on the costs incurred by the NHS from 2008 to 2016 (direct costs related to hospitalizations) and by the National Social Security Institute (INPS) from 2009 to 2015 (costs of social security benefits) for patients with breast cancer. The analysis was based on the Hospital Information System (HIS) and Disability Insurance Awards databases. For both databases, patients affected by a malignant neoplasm of the female breast, carcinoma in situ, or secondary malignant neoplasm of the breast were considered. Results: Results show that more than 75,000 women were hospitalized for breast cancer every year, with an overall cost for hospitalization of about €300 million per year. From the Social Security analysis, a number of 29,000 beneficiaries each year was estimated. Considering per patient social costs, breast cancer at the primary stage cost €8828 per year, while secondary neoplasms cost €9780, with an average total economic burden of €257 million per year. Conclusions: This analysis focused on the economic impact of breast cancer in Italy, showing that an advanced stage of the disease was associated with a higher cost. MDPI 2021-08-26 /pmc/articles/PMC8431604/ /pubmed/34501588 http://dx.doi.org/10.3390/ijerph18179005 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mennini, Francesco Saverio
Trabucco Aurilio, Marco
Gazzillo, Simone
Nardone, Claudia
Sciattella, Paolo
Marcellusi, Andrea
Migliorini, Raffaele
Sciannamea, Valerio
Piccioni, Andrea
Bolcato, Matteo
Barni, Sandro
An Analysis of the Social and Economic Costs of Breast Cancer in Italy
title An Analysis of the Social and Economic Costs of Breast Cancer in Italy
title_full An Analysis of the Social and Economic Costs of Breast Cancer in Italy
title_fullStr An Analysis of the Social and Economic Costs of Breast Cancer in Italy
title_full_unstemmed An Analysis of the Social and Economic Costs of Breast Cancer in Italy
title_short An Analysis of the Social and Economic Costs of Breast Cancer in Italy
title_sort analysis of the social and economic costs of breast cancer in italy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431604/
https://www.ncbi.nlm.nih.gov/pubmed/34501588
http://dx.doi.org/10.3390/ijerph18179005
work_keys_str_mv AT menninifrancescosaverio ananalysisofthesocialandeconomiccostsofbreastcancerinitaly
AT trabuccoauriliomarco ananalysisofthesocialandeconomiccostsofbreastcancerinitaly
AT gazzillosimone ananalysisofthesocialandeconomiccostsofbreastcancerinitaly
AT nardoneclaudia ananalysisofthesocialandeconomiccostsofbreastcancerinitaly
AT sciattellapaolo ananalysisofthesocialandeconomiccostsofbreastcancerinitaly
AT marcellusiandrea ananalysisofthesocialandeconomiccostsofbreastcancerinitaly
AT miglioriniraffaele ananalysisofthesocialandeconomiccostsofbreastcancerinitaly
AT sciannameavalerio ananalysisofthesocialandeconomiccostsofbreastcancerinitaly
AT piccioniandrea ananalysisofthesocialandeconomiccostsofbreastcancerinitaly
AT bolcatomatteo ananalysisofthesocialandeconomiccostsofbreastcancerinitaly
AT barnisandro ananalysisofthesocialandeconomiccostsofbreastcancerinitaly
AT menninifrancescosaverio analysisofthesocialandeconomiccostsofbreastcancerinitaly
AT trabuccoauriliomarco analysisofthesocialandeconomiccostsofbreastcancerinitaly
AT gazzillosimone analysisofthesocialandeconomiccostsofbreastcancerinitaly
AT nardoneclaudia analysisofthesocialandeconomiccostsofbreastcancerinitaly
AT sciattellapaolo analysisofthesocialandeconomiccostsofbreastcancerinitaly
AT marcellusiandrea analysisofthesocialandeconomiccostsofbreastcancerinitaly
AT miglioriniraffaele analysisofthesocialandeconomiccostsofbreastcancerinitaly
AT sciannameavalerio analysisofthesocialandeconomiccostsofbreastcancerinitaly
AT piccioniandrea analysisofthesocialandeconomiccostsofbreastcancerinitaly
AT bolcatomatteo analysisofthesocialandeconomiccostsofbreastcancerinitaly
AT barnisandro analysisofthesocialandeconomiccostsofbreastcancerinitaly